Management Team
Dr. Francesco Bellini
Dr. Francesco Bellini is an Officer of the Order of Canada and recognized as a pioneer in bio-pharma. Until 2001, Dr. Bellini was the Chairman of the board of directors and Chief Executive Officer of BioChem Pharma Inc., a biopharmaceutical company focused on infectious diseases and cancer, which he co-founded in 1986. Dr. Bellini currently serves as Chairman of the board of directors of Ascoli Picchio F.C. 1898 S.p.A., Bellus Health Inc., Domodimonti Srl Società Agricola, FB Health S.p.A., Iniziative Immobiliari Marchigiane Srl, and Picchio International Inc., and previously served as chairman of the board of directors of ViroChem Pharma Inc. From 1997 to June 2014, Dr. Bellini served on the board of directors of Molson Coors Brewing Company Inc. Dr. Bellini received his Bachelor of Science degree from Concordia University and his PhD in organic chemistry from the University of New Brunswick.
Mr. Joseph D'Abramo
Mr. Joseph D’Abramo, CPA, CA, is currently the Senior Director of Finance, Controller & Corporate Secretary at Klox Technologies Inc. He leads the Accounting and Finance functions at Klox and has been serving the entity since 2014. Prior to joining the company, Mr. D’Abramo worked at Deloitte whereby he spent almost 10 years of his career attaining the rank of Senior Manager in the Assurance & Advisory group. He specialized in serving both large public and private entities, mainly in the technology sector, and has extensive industry knowledge of accounting and financial reporting, financial planning & analysis and corporate finance. Mr. D’Abramo holds a Bachelor of Commerce in Accounting and a Graduate Diploma in Chartered Accountancy from the John Molson School of Business in Montreal, Canada.
Mr. Carlo Bellini
Carlo Bellini is President at Klox and has served as a member of our board of directors since April 2009. Mr. Bellini previously served as Managing Director of Vitus Capital Holdings Ltd., a private U.K. fund, from June 2011 to September 2014. He served as President of Domodimonti Srl, an Italian agricultural company, between April 2009 and June 2011. Prior to 2009, Mr. Bellini worked in different capacities at a variety of funds. Mr. Bellini received his Bachelor of Arts in Finance from McGill University.
Mr. Jason Gugliuzza
Jason Gugliuzza serves as our Senior Vice-President Global Marketing and Sales since June 2017. Prior to joining our company Mr. Gugliuzza held various senior sales and marketing positions for several multinational organizations. Most recently, he served as the Senior Vice-President for Japan and Asia at Acelity.
Previously he was the Regional Vice President and Vice-President of Commercial strategy for the Emerging Markets region at Acelity working across all of the Asia, MENA and Latin American regions.
A seasoned Sales and marketing professional with twenty years working in healthcare, he has worked and lived in Europe, Asia and North America with experience of the Wound Care, Respiratory Pharmaceuticals and Dermatology segments, specifically with companies such as AstraZeneca, Smith and Nephew and ConvaTec.
Mr. Gugliuzza holds an MBA from the University of Durham, an MSc in International Business and Corporate Finance and an undergraduate degree in Economics.
Dr. Lise Hébert
Lise Hébert, PhD has served as a member of our board of directors since April 2009. Prior to joining our company, Dr. Hébert served as vice president of Corporate Communications at Bellus Health Inc., a biotechnology company, for over 10 years. She currently serves on the Life Sciences Committee of the Fédération des Chambres du Commerce du Québec.
Dr. Hébert holds a PhD in Experimental Medicine from McGill University, where her research focused on amyloidosis and during which time she also conducted research at New York University Medical School. Dr. Hébert completed her post-doctoral studies at the Lady Davis Research Institute at the Montreal Jewish General Hospital and is the author of several patents.
Dr. Daniela Jukic
Daniela Jukic, PHD has served as senior director of Regulatory Affairs Compliance and Quality Assurance since 2016.
Dr. Jukic has extensive regulatory and compliance experience covering Prescription, Blood Products, Cells Tissues & Organs, OTC, Rx-to-OTC Switch, NHP, DIN to NHP transition, Medical Devices, Cosmetic and Consumer Care products.
Prior to joining our company, Dr. Jukic has over 20 years of experience in pharma as Director Regulatory Affairs and Compliance for firms such as Pfizer/Pharmacia, Merck Canada, Schering Canada/Bayer and at Hema-Quebec.
Dr. Jukic holds a PhD in Pharmacology from the Faculty of Medicine, University of Sherbrooke.
Dr. Stéphane Fauverghe
Dr. Stéphane Fauverghe, M.D. is currently Senior Director, Clinical and Medical Affairs. Dr. Fauverghe leads the clinical programs through the development of clinical trials in Europe and North-America, and the medical strategy by developing the international network of key advisors. He is also in charge of medical communications supporting healthcare professionals who are developing experience with fluorescence biomodulation technology. Dr. Fauverghe has over 12 years of experience in Clinical and Medical affairs, including Dermatology and Wound Healing programs. Prior to joining our company he worked at Pierre Fabre group from 2005 to 2012 in various roles including Medical Director where he was in charge of medical strategy, relations with Key Opinion Leaders and market access programs.
Dr. Fauverghe holds a Medical Degree from the University of Lyon and an MBA from ESSEC Business School (Paris).